Merck extends Keytruda exclusivity with aggressive patents, costing patients over $200,000 annually.

EU approves Dupixent for young children with chronic urticaria.

Spyre Therapeutics shares surge on positive Phase 2 ulcerative colitis trial results.

Veterinary drug fenbendazole gains renewed interest amid consumer demand and early studies.

Reach Surgical's iREACH IRIS stapler received CE Mark approval for real-time force feedback.

Zimbabwe recalls Azithromycin batch due to quality defects.

World Tumor Registry launches new digital platform to improve global breast cancer diagnosis.

Boston Scientific invests €75M in Galway facility for R&D expansion.

AliveCor launches AI-powered Kardia12L ECG device in Europe.

OBI Pharma presents GlycOBI platform for next-gen antibody-drug conjugates at 2026 AACR meeting.